Treatment strategies for hot flushes

Research output: Contribution to journalArticle

Abstract

Background: Vasomotor symptoms are the most common complaints for which menopausal women seek medical care. Eighty per cent of all menopausal women will have hot flushes and night sweats, and of these 9% will have severe symptoms impacting their quality of life. Ideally, treatment should target the group most severely afflicted, and options for treatment should be tailored to each woman, since, for most women, vasomotor symptoms spontaneously resolve in 3 - 5 years. Recommendation at this time is for the shortest duration of therapy, which means that episodic review of therapy is indicated. Objective: To review the latest literature investigating therapies for vasomotor symptoms and to discuss their effectiveness with emphasis on placebo-controlled, randomized clinical trials. Methods: A literature search in PubMed for 'vasomotor symptoms', 'menopause symptoms', 'hot flushes', 'hot flashes' and 'night sweats' from 2003 to the present was performed. Conclusions: Estrogen remains the gold standard for treating vasomotor symptoms. As investigations into the physiology of hot flushes continue, centrally active drugs (selective serotonin or norepinephrine-serotonin reuptake inhibitors and gabapentin) have increased in use. The benefit from dietary herbal supplements is still inconclusive; however, recent studies have shown some mild response to soy and black cohosh.

Original languageEnglish (US)
Pages (from-to)1133-1144
Number of pages12
JournalExpert Opinion on Pharmacotherapy
Volume10
Issue number7
DOIs
StatePublished - May 2009

Fingerprint

Sweat
Cimicifuga
Hot Flashes
Serotonin Agents
Therapeutics
Menopause
Dietary Supplements
PubMed
Estrogens
Randomized Controlled Trials
Placebos
Quality of Life
Serotonin and Noradrenaline Reuptake Inhibitors
gabapentin

Keywords

  • Gabapentin
  • Herbal supplements
  • Hormone therapy
  • Hot flushes
  • Menopause
  • Night sweats
  • SNRI
  • SSRI
  • Vasomotor symptoms

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Treatment strategies for hot flushes. / Shen, Wen; Stearns, Vered.

In: Expert Opinion on Pharmacotherapy, Vol. 10, No. 7, 05.2009, p. 1133-1144.

Research output: Contribution to journalArticle

@article{2d5e4a8bf1df4c83bd0315009a52ebd8,
title = "Treatment strategies for hot flushes",
abstract = "Background: Vasomotor symptoms are the most common complaints for which menopausal women seek medical care. Eighty per cent of all menopausal women will have hot flushes and night sweats, and of these 9{\%} will have severe symptoms impacting their quality of life. Ideally, treatment should target the group most severely afflicted, and options for treatment should be tailored to each woman, since, for most women, vasomotor symptoms spontaneously resolve in 3 - 5 years. Recommendation at this time is for the shortest duration of therapy, which means that episodic review of therapy is indicated. Objective: To review the latest literature investigating therapies for vasomotor symptoms and to discuss their effectiveness with emphasis on placebo-controlled, randomized clinical trials. Methods: A literature search in PubMed for 'vasomotor symptoms', 'menopause symptoms', 'hot flushes', 'hot flashes' and 'night sweats' from 2003 to the present was performed. Conclusions: Estrogen remains the gold standard for treating vasomotor symptoms. As investigations into the physiology of hot flushes continue, centrally active drugs (selective serotonin or norepinephrine-serotonin reuptake inhibitors and gabapentin) have increased in use. The benefit from dietary herbal supplements is still inconclusive; however, recent studies have shown some mild response to soy and black cohosh.",
keywords = "Gabapentin, Herbal supplements, Hormone therapy, Hot flushes, Menopause, Night sweats, SNRI, SSRI, Vasomotor symptoms",
author = "Wen Shen and Vered Stearns",
year = "2009",
month = "5",
doi = "10.1517/14656560902868217",
language = "English (US)",
volume = "10",
pages = "1133--1144",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Treatment strategies for hot flushes

AU - Shen, Wen

AU - Stearns, Vered

PY - 2009/5

Y1 - 2009/5

N2 - Background: Vasomotor symptoms are the most common complaints for which menopausal women seek medical care. Eighty per cent of all menopausal women will have hot flushes and night sweats, and of these 9% will have severe symptoms impacting their quality of life. Ideally, treatment should target the group most severely afflicted, and options for treatment should be tailored to each woman, since, for most women, vasomotor symptoms spontaneously resolve in 3 - 5 years. Recommendation at this time is for the shortest duration of therapy, which means that episodic review of therapy is indicated. Objective: To review the latest literature investigating therapies for vasomotor symptoms and to discuss their effectiveness with emphasis on placebo-controlled, randomized clinical trials. Methods: A literature search in PubMed for 'vasomotor symptoms', 'menopause symptoms', 'hot flushes', 'hot flashes' and 'night sweats' from 2003 to the present was performed. Conclusions: Estrogen remains the gold standard for treating vasomotor symptoms. As investigations into the physiology of hot flushes continue, centrally active drugs (selective serotonin or norepinephrine-serotonin reuptake inhibitors and gabapentin) have increased in use. The benefit from dietary herbal supplements is still inconclusive; however, recent studies have shown some mild response to soy and black cohosh.

AB - Background: Vasomotor symptoms are the most common complaints for which menopausal women seek medical care. Eighty per cent of all menopausal women will have hot flushes and night sweats, and of these 9% will have severe symptoms impacting their quality of life. Ideally, treatment should target the group most severely afflicted, and options for treatment should be tailored to each woman, since, for most women, vasomotor symptoms spontaneously resolve in 3 - 5 years. Recommendation at this time is for the shortest duration of therapy, which means that episodic review of therapy is indicated. Objective: To review the latest literature investigating therapies for vasomotor symptoms and to discuss their effectiveness with emphasis on placebo-controlled, randomized clinical trials. Methods: A literature search in PubMed for 'vasomotor symptoms', 'menopause symptoms', 'hot flushes', 'hot flashes' and 'night sweats' from 2003 to the present was performed. Conclusions: Estrogen remains the gold standard for treating vasomotor symptoms. As investigations into the physiology of hot flushes continue, centrally active drugs (selective serotonin or norepinephrine-serotonin reuptake inhibitors and gabapentin) have increased in use. The benefit from dietary herbal supplements is still inconclusive; however, recent studies have shown some mild response to soy and black cohosh.

KW - Gabapentin

KW - Herbal supplements

KW - Hormone therapy

KW - Hot flushes

KW - Menopause

KW - Night sweats

KW - SNRI

KW - SSRI

KW - Vasomotor symptoms

UR - http://www.scopus.com/inward/record.url?scp=67649559803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649559803&partnerID=8YFLogxK

U2 - 10.1517/14656560902868217

DO - 10.1517/14656560902868217

M3 - Article

C2 - 19405789

AN - SCOPUS:67649559803

VL - 10

SP - 1133

EP - 1144

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 7

ER -